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Abstract NMR spectroscopic characterization of the
structure or the dynamics of proteins generally requires
the production of samples isotopically enriched in
15N,
13C,
or
2H. The bacterial expression systems currently in use
to obtain isotopic enrichment, however, cannot produce a
number of eukaryotic proteins, especially those that require
post-translational modiﬁcations such as N-linked glyco-
sylation for proper folding or activity. Here, we report the
use of an adenovirus vector-based mammalian expression
system to produce isotopically enriched
15No r
15N/
13C
samples of an outer domain variant of the HIV-1 gp120
envelope glycoprotein with 15 sites of N-linked glycosyl-
ation. Yields for the
15N- and
15N/
13C-labeled gp120s after
afﬁnity chromatography were 45 and 44 mg/l, respectively,
with an average of over 80% isotope incorporation. Rec-
ognition of the labeled gp120 by cognate antibodies that
recognize complex epitopes showed afﬁnities comparable
to the unlabeled protein. NMR spectra, including
1H-
15N
and
1H-
13C HSQCs,
15N-edited NOESY-HSQC, and 3D
HNCO, were of high quality, with signal-to-noise
consistent with an efﬁcient level of isotope incorporation,
and with chemical shift dispersion indicative of a well-
folded protein. The exceptional protein yields, good iso-
tope incorporation, and ability to obtain well-folded post-
translationally modiﬁed proteins make this mammalian
system attractive for the production of isotopically enri-
ched eukaryotic proteins for NMR spectroscopy.
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Introduction
Structural studies of proteins and their complexes by NMR
spectroscopy often require incorporation of
15N,
13C, or
2H
stable isotopes. In the vast majority of examples, E. coli
expression systems have been used for isotope labeling,
because of their ability to provide efﬁcient incorporation
of stable isotopes and high levels of protein production.
Bacterial protein production systems, however, fail to
produce well-folded proteins for numerous protein classes.
These include many eukaryotic proteins, particularly those
that are secreted, have multiple disulﬁde bonds, require
speciﬁc chaperones, require speciﬁc prosthetic groups, or
are post-translationally modiﬁed. Despite extensive efforts
with solubility enhancing fusion tags, lower growth tem-
perature, co-expression with eukaryotic chaperones, peri-
plasmic expression, and other methods such as creation of
an oxidizing environment in the bacterial cytoplasm, only
moderate improvements in success rate have been obtained
(Schein and Noteborn 1988; Bessette et al. 1999; Cornelis
2000; Kadokura and Beckwith 2001; Esposito and Chat-
terjee 2006).
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DOI 10.1007/s10858-011-9506-4By contrast, eukaryotic proteins can often be efﬁciently
produced in their native form by mammalian cell lines such
as human embryonic kidney (HEK) 293 cells and Chinese
hamster ovary (CHO) cells. A number of investigators have
attempted to produce isotopically labeled proteins using
such mammalian expression systems. In an early study,
Hansen and colleagues used a mixture of isotopically
labeled amino acids derived from bacterial or algal
hydrolysates to obtain 0.5 mM uniformly
15N-labeled
urokinase from 0.75 to 1.0 l culture medium from the
mouse myeloma Sp2/0 cell line (Hansen et al. 1992). Wyss
and colleagues subsequently reported expression of human
CD2 with
15N-labeled lysine residues using stably trans-
fected CHO cells and media containing isotopically labeled
lysine (Wyss et al. 1993, 1997), and a strategy incorpo-
rating a mixture of labeled amino acids has been used
to obtain 10 mg/l of uniformly labeled
15N- and
15N/
13C-
labeled human chorionic gonadotropin from a stably
transfected CHO cell line (Lustbader et al. 1996). A similar
strategy was used to produce
15N- and
15N/
13C-labeled
IgG2a antibody from a mouse hybridoma cell line (Shindo
et al. 2000), and Werner and colleagues used a subset of
15N and
15N/
13C amino acids (G, K, L, Q, S, T, V, and W)
to label rhodopsin expressed from HEK293 cells with an
average yield of 2 mg/l puriﬁed protein (Werner et al.
2008). More recently, Skelton and colleagues reported the
development of a reduced nutrient media formulation for
Lec1 cells, a glycosylation deﬁcient CHO cell line, to
obtain partially labeled proteins (Skelton et al. 2010).
Unfortunately, a majority of the published methods for
obtaining isotopically labeled proteins from eukaryotic
expression systems require labor intensive optimization of
synthetic media, a problem that is often compounded by
low yields. As a result, the use of mammalian expression
systems has often been limited to amino-acid type-speciﬁc
labeling (Arata et al. 1994; Klein-Seetharaman et al. 2002,
2004).
A eukaroytic expression system capable of expressing
isotopically labeled, well-folded, post-translationally
modiﬁed proteins at high yield from commercially avail-
able media has thus been widely sought. One such system,
which uses an adenovirus vector coupled to mammalian
expression, was developed for the expression of transgenes
in the context of vaccines and gene therapy (Nabel 1999;
Barouch and Nabel 2005). Recombinant adenovirus,
wherein the E1 region has been deleted, is replication
incompetent, and a further deletion of the E3 region allows
for insertion of up to 8-kilobases of recombinant trans-
genes. A very high efﬁciency of transfection and speciﬁc
translational discrimination between viral and cellular
mRNA together facilitate the exceptional expression of
adenovirus-vectored proteins from mammalian cells
(Babich et al. 1983; Huang and Schneider 1990). We found
this system capable of expressing the HIV-1 gp120 enve-
lope glycoprotein, which has 9 disulﬁdes and *20 sites
of N-linked glycosylation, at a level of *50 mg/l for
wild-type and various truncated variants (Zhou et al. 2007;
Wang et al. 2009), a level of expression substantially better
than achieved by transient transfection or from transformed
drosophila cells (Kwong et al. 2010). As precise mea-
surement of the ﬂexibility of HIV-1 gp120 may provide
insight into its immunogenicity, we sought to produce an
isotopically labeled fragment of HIV-1 gp120 that con-
tained the epitope for broadly neutralizing antibodies and
that was sufﬁciently small and well behaved to be analyzed
by NMR spectroscopy. Herein, we report an efﬁcient
method to isotopically enrich proteins from a mammalian
system that exploits the high level of protein expression
obtained from an adenoviral vector. We demonstrate the
method for an outer domain variant of HIV-1 gp120,
comprising 229 amino acids, 15 potential sites of N-linked
glycosylation, and four disulﬁde bonds. This outer domain
variant also contains the initial attachment site of HIV-1 to
the CD4 receptor, a site of HIV-1 vulnerability to neu-
tralizing antibodies and therefore of vaccine importance
(Zhou et al. 2007, 2010; Wu et al. 2009).
Materials and methods
Restriction enzymes and transfection system
BamH1, Xba1, Sac1, Cla1 were obtained from New
England Biolabs. Cre recombinase was obtained from
Novagen (Madison, WI). ProFection
 Mammalian Trans-
fection System was obtained from Promega (Madison, WI).
Media and isotopes
High glucose containing, pyruvate-free Dulbecco’s modi-
ﬁed Eagle medium (DMEM) with HEPES, NaHCO3,
dialyzed fetal bovine serum (FBS), trypsin–EDTA, and
penicillin/streptomycin were obtained from Invitrogen.
Inc (Carlsbad, CA).
15N-CGM6000 (U-98%),
15N/
13C-
CGM6000 (U-98%) containing HEPES and NaHCO3,
EDTA-d12 (98%), Tris-D11 (98%), and D2O (D, 99.8%)
were purchased from Cambridge Isotopes Limited (Ando-
ver, MA). Sodium pyruvate was purchased from Sigma–
Aldrich (St. Louis, MO).
Cell lines and growth in protonated and deuterated
media
HEK 293 and A549 cells used in this work were obtained
from American Type Culture Collection (Manassas, VA).
A549 cells were grown in DMEM with 25 mM HEPES,
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12310% heat inactivated dialyzed fetal bovine serum (FBS),
and 1% penicillin/streptomycin. A549 cells were split to
desired density, centrifuged at 360 g for 10 min and
resuspended in appropriate media (DMEM,
15N-CGM6000,
or
15N/
13C-CGM6000 with and without pyruvate). Cells
were recounted prior to plating in 6 well plates at 0.21 9
10
6cells/well and incubated at 37C for 7 days. Aliquots
were taken every 24 h and cells counted in triplicate for
each media type. For deuterated media, A549 cells were
initially adapted to 20% D2O-containing DMEM, 10% heat
inactivated FBS and 1% penicillin/streptomycin (Murphy
et al. 1977) for a few days before seeding at 1 9 10
6 cells/
plate (10 cm diameter) in DMEM containing 20, 45 or 70%
D2O. Viable cells were counted every 24 h for 10 days to
obtain growth curves.
Recombinant adenovirus vectors
Recombinant adenovirus type 5 (Ad5)-green ﬂuorescent
protein (GFP) and Ad5-HIV-1 gp120 outer domain were
constructed by homologous recombination as described
previously (Aoki et al. 1999). In brief, the shuttle vectors
containing GFP or outer domain DNA constructs were
recombined with a cosmid which carries Ad5 genomic
DNA. The Ad5 genomic DNA lacks the E1 region and has
a non-functional E3 region. The recombinations were
carried out using Cre recombinase (Novagen, Madison,
Wis.). The Ad5 viruses were puriﬁed twice using CsCl
gradient centrifugation, followed by a desalting column to
remove the CsCl. The expression of GFP gene was under
the control of an RSV promoter (Ohno et al. 1997). The
expression of gp120 outer domain was under the control of
a CMV promoter and the construct has a C-terminal
HRV3C cleavage site followed by a His6 puriﬁcation tag.
The aforementioned adenoviral vectors are available upon
request from GJN; commercial adenovirus expression
systems are also available (such as ‘‘ViraPower’’ from
Invitrogen).
Green ﬂuorescent protein expression and puriﬁcation
The HEK 293 and A549 cells were seeded at 0.8 9 10
6
cells/well in a six well plate on day-1. The following day,
media was replaced with fresh DMEM,
15N CGM6000,
15N/
13C CGM6000 or 70% D2O containing unlabeled
media. 293 cells were transfected with a plasmid contain-
ing the gene for GFP using lipofectamine 2000 (Invitrogen)
as the tranfection agent. A control vector pVRC8400 was
also transfected as a negative control. A549 cells were
infected with a recombinant adenovirus (rAdGFP) that
contained a gene for GFP. The time course of protein
expression was followed by harvesting both HEK 293 and
A549 cells at 24 h intervals over a period of 6 days post
transfection with plasmid DNA or post infection by
recombinant adenovirus. Cells were lysed, and the pro-
duction of GFP quantiﬁed by measuring the ﬂuorescence of
crude cell lysates and comparing to a standard curve
(Biovision).
A549 adherent cells were maintained in DMEM. Typi-
cally, cells were seeded in 15 cm plates at 12–15 9 10
6
cells/plate on day-1 in fresh DMEM containing 10% heat
inactivated dialyzed FBS, 1% penicillin/streptomycin and
allowed to grow overnight at 37C. The following day,
media was replaced with labeled
15N,
15N/
13C CGM6000
or fresh DMEM. A549 cells were infected with rAdGFP
to a ﬁnal concentration of 2,500 particles/cell. Protein
expression was monitored by following the ﬂuorescence
signal of GFP; 72–96 h post infection cells were washed
with PBS, lifted off with trypsin–EDTA, and pelleted at
360 g rpm for 150, and the cell pellet washed with PBS and
stored at -80C until further use. Cell pellet was resus-
pended in 10 ml cell lysis buffer (Cell Signaling), placed
on ice for 10 min, nutated at 4C for 1 h and the lysate
spun down at 14,000 rpm at 4C for 40 min. The cleared
lysate was immediately loaded onto an anti-GFP afﬁnity
column, nutated at 4C overnight and subsequently washed
with PBS. GFP was eluted using 25 mM Tris and 3 M
MgCl2, pH 7.4. Fractions containing GFP were pooled;
concentrated and desalted using a PD10 column, and purity
of GFP was analyzed by SDS–PAGE.
HIV-1 gp120 outer domain expression and puriﬁcation
A549 cells were seeded at 12–15 9 10
6 cells/plate on
day-1 in fresh DMEM containing 10% heat inactivated
dialyzed FBS, 1% penicillin–streptomycin and allowed to
grow overnight at 37C. The following day, media was
replaced with
15N,
15N/
13C CGM6000 or fresh DMEM
containing the glycosidase inhibitors kifunensine (12.5 mg/l)
and swainsonine (5 mg/l). A549 cells were infected with
recombinant adenovirus containing the gene for HIV-1
gp120 outer domain (rAdOD) 1–2 h later to a ﬁnal con-
centration of 2,500 particles/cell. The culture supernatant
was harvested 96–108 h post infection; cell debris was
spun down at 365 g for 15 minutes. The culture supernatant
was ﬁltered and the outer domain was puriﬁed by immo-
bilized nickel- and antibody b12-afﬁnity chromatography.
Fractions containing the outer domain were pooled, con-
centrated, dialyzed against PBS and deglycosylated using
EndoHf followed by size-exclusion chromatography.
Quantiﬁcation of isotope incorporation
To quantify the extent of isotope incorporation, unlabeled,
15N/
13C-labeled,
15N-labeled and deglycosylated HIV-1
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123outer domain and GFP were subjected to tryptic digestion
followed by MALDI TOF mass spectrometry (see Sup-
plementary methods). A modiﬁed algorithm based on the
approaches of Kubinyi (1991) was used to compute the-
oretical estimates of isotopic distributions using isotope
masses and abundances described previously (Kubinyi
1991) (Table S3). In this modiﬁed algorithm, the
15N
abundance was calculated between 0 and 100% at incre-
ments of 1%, and for each percent-
15N value, the isotope
distribution pattern was computed as follows. The isotope
distribution pattern for each element was computed
separately and peaks with intensities less than a cutoff
threshold were discarded (a cutoff of 10
-7 was used). The
isotope distribution patterns for the different elements
were then combined to obtain the overall distribution
pattern for the given
15N abundance percentage. ‘Major’
peaks were deﬁned to be peaks at integral distances from
the mono-isotopic peak. The intensities for all peaks with
masses within a cutoff threshold from a given major peak
were added to the intensity of the major peak (a mass
cutoff of 0.3 was used), thus forming ‘super-peaks.’ The
highest super-peak intensity was set to 100 and all other
super-peak intensities were normalized accordingly. Only
signiﬁcant super-peaks with intensities (after normaliza-
tion) greater than a cutoff threshold were output (a cutoff
of 10
-4 was used); the intensities of all other super-peaks
were set to zero. Once the isotope distribution patterns
for all
15N abundance percentages were computed, these
patterns were compared against the observed mass spec-
trometry (M/S) spectra. Computed patterns for which the
mass of the highest-intensity peak did not match the mass
of the highest-intensity peak in the observed M/S spectra
were discarded from further consideration. A range of
possible incorporation percentages was obtained from the
remaining computed patterns. For each of the patterns, the
correlation between that pattern and the observed M/S
pattern (using the heights of the M/S peaks) was computed
using linear regression analysis. For the outer domain
peptide, no adjustment for noise was performed on the
M/S pattern. Correlation computation for outer domain
included the peaks in the mass range 842.5–869.5, span-
ning the observed M/S peaks for that peptide. A similar
grid search was performed for the double labeled outer
domain to obtain an estimate of the percentage incorpo-
ration of
13C while utilizing the estimate of
15N incor-
poration from the analysis of the
15N labeled outer domain
(see supplemental material). For the GFP peptide, the M/S
pattern was adjusted for noise, resulting in a total of seven
M/S peaks in the mass range 1,355–1,362. Correlation
computation for GFP included the peaks in the mass
range 1,347.7–1,378.7, corresponding to the mass range
in which all computed signiﬁcant super-peaks were
observed; missing M/S peaks within this range were set to
zero.
Surface plasmon resonance
To characterize the state of GFP, an anti-GFP antibody
ab1218 (Abcam) was directly immobilized onto a Biacore
CM5 sensor chip to a ﬁnal surface density of *500 RU.
Unlabeled,
15N- and
15N/
13C-labeled GFP were used as
analytes at concentrations ranging from 3.9 to 62.5 nM,
at two-fold serial dilutions. Similarly for the binding of
HIV-1 gp120 outer domain antibodies b13 and b12 were
directly immobilized onto Biacore CM5 sensor chips to
a ﬁnal surface density of *500 RU. Unlabeled,
15N-, and
15N/
13C-labeled outer domain were used as analytes at
concentrations ranging from 3.9 to 250 nM, at two-fold
serial dilutions.
NMR spectroscopy
NMR experiments were acquired on a Bruker Avance
900 MHz spectrometer equipped with a 5 mm TCI cryo-
probe. Spectra were acquired on the deglycosylated
15N
and
15N/
13C labeled HIV-1 gp120 outer domain a
*28 kDa protein with a concentration of 0.4 mM in
90%H2O/10%D2O at a pH of 7.0 and a temperature of
25C. Standard Bruker pulse sequences were used for
1H-
15N HSQC,
1H-
13C HSQC,
15N-edited NOESY-HSQC
and the HNCO experiment (Yamazaki et al. 1994), with
States-TPPI quadrature detection. Water suppression was
achieved by WATERGATE (Sklenar et al. 1993) and water
ﬂip back pulses. The HSQC spectra were acquired with
1,024 complex points in the direct dimension and with
spectral widths of 13,550 and 2,919 Hz in the proton and
nitrogen dimensions, respectively and 256, points in the
nitrogen dimension. The
1H-
13C HSQC spectra were
acquired with 1,024 points in the direct dimension and with
spectral widths of 10,776 and 18,108 Hz in the proton
and carbon dimension, respectively with 300 points in the
carbon dimension. The 3D HNCO (Kay et al. 1990;
Grzesiek and Bax 1992) spectrum was recorded with 512,
32 and 25 complex points in proton, nitrogen and carbon
dimensions, with spectral widths of 10,776, 2,919 and
4,528 Hz in the proton nitrogen and carbon dimensions,
respectively. Recycle delays of 1 s were used for all
experiments. Data sets were processed using NMRPipe
(Delaglio et al. 1995).
15N dimensions were extended to 64
complex points with linear prediction. Both
15N and
13C
dimensions were apodized with a shifted squared sine-bell
apodization function and zero ﬁlled to 256 complex points
prior to Fourier transformation. All data were analyzed
with the program CARA (Keller 2004).
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Mammalian expression system using adenoviral
and transient transfection vectors
To provide an initial assessment of the ability of adeno-
virus vectors to produce a folded eukaryotic protein in
isotopically labeled media, we tested the expression of
GFP, which permitted quantiﬁcation directly from crude
cell lysates by ﬂuorescence. We tested two expression
systems, an adenovirus-vectored approach with A549 cells
and a transient transfection approach with HEK293 cells,
on four different media. These included unlabeled DMEM,
two commercially-available CGM6000 media isotopically
labeled with
15No r
15N/
13C, and unlabeled DMEM made
from 70% D2O (Fig. 1). With all four media, the expres-
sion from the adenovirus vector was substantially higher
than from transient expression. More notable was the
consistent level of expression in all four media, suggesting
that expression in labeled media did not substantially
alter adenovirus-vectored protein expression. This level of
expression was especially surprising for 70% D2O media as
growth of the A549 cells in this media was substantially
slower (Fig. S1), and, in the case of 293 cells, resulted in
extensive cell death by day four following transfection.
Characterization and quantiﬁcation of isotopic
incorporation in GFP
To quantify the degree of isotope enrichment in the ade-
novirus vector-expressed GFP, we expressed, puriﬁed and
characterized GFP from A549 cells infected with recom-
binant adenovirus containing the GFP gene. Puriﬁcation by
immune-afﬁnity chromatography gave GFP with purity
greater than 95% by SDS–PAGE (Fig. S2). We obtained
milligram quantities of GFP from unlabeled,
15N-, and
15N/
13C-labeled media. Surface plasmon resonance analysis
with the anti-GFP antibody ab1218 showed similar KDs
(0.85–3.9 nM) for labeled and unlabeled samples (Fig. S2).
We encountered difﬁculties obtaining mass spectral data
on intact GFP, and since we knew that the assessment of
the glycosylated outer domain would require fragmentation,
we assessed isotope incorporation using a combination of
tryptic digestion and MALDI TOF mass spectrometry. In
mass spectra of unlabeled GFP, three peptides with the
sequences FSVSGEGEGDATYGK (1,503.5 amu), TIFF-
KDDGNYK (1,347.4 amu), SAMPEGYVQER (1,266.3
amu) gave high quality peaks; in mass spectra of the labeled
samples, however, overlapping peaks and poor quality data
for the 1,503.5 and 1,266.3 peptides limited our analysis to
the TIFFKDDGNYK peptide, with the percent incorpora-
tion of
15N estimated at 72 ± 3%, and the best ﬁtting
computed spectrum showing 74% (Table S1, Fig. S2).
HIV-1 gp120 outer domain: expression and antigenic
characterization
Because the full-length HIV-1 gp120 glycoprotein is over
500 amino acids in size, we sought to produce a biologi-
cally relevant fragment more conducive to NMR analysis.
One potential fragment, an outer domain variant, was ini-
tially described by Sodroski and colleagues (Yang et al.
2004) and spanned gp120 residues 252–482 (numbering for
gp120 residues follows the standard HXBc2 numbering
scheme (Korber et al. 1998)). This fragment contained the
initial site of HIV-1-engagement of the CD4 receptor and
Fig. 1 Time course of GFP expression in transient versus adenoviral
expression system. Protein production in an adenoviral expression
system with A549 cells is superior to transient transfection with HEK
293 cells. a Transient expression of GFP in 293 cells (ﬁlled square)
versus A549 cells/adenoviral expression (circle) in DMEM. b Tran-
sient expression of GFP in 293 cells (ﬁlled square) versus A549 cells/
adenoviral expression (circle)i n
15N labeled CGM6000 media.
c Transient expression of GFP in 293 cells (ﬁlled square) versus A549
cells/adenoviral expression (circle)i n
15N/
13C labeled CGM6000.
d Transient expression of GFP in 293 cells (ﬁlled square) versus
A549 cells/adenoviral expression (circle) in 70% D2O containing
unlabeled media. In the 70% D2O containing media, a large
percentage of HEK 293 cells are dead ﬁve days post transfection.
A549 cells, however, do not appear to be as affected as HEK 293 cells
by the 70% D20 containing media: in particular, expression from
adenovirus-vectored genes does not appear to be strongly affected by
the presence of 70% D2O containing media, although the cells do not
appear to grow (Fig. S1). All measurements were made in duplicate,
SEM error bars are displayed for the time course of protein
expression
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123was therefore of substantial vaccine interest. The initial
outer domain version, however, showed reduced binding to
broadly neutralizing anti-HIV-1 antibodies such as b12 and
also contained the ﬂexible third variable loop (V3), which
is immunodominant. Various modiﬁcations restored b12
afﬁnity (Wu et al. 2009; Kanekiyo et al. 2010; Xu et al.
2010), and we settled on a construct composed of gp120
residues 252–482, with V3 truncation and other modiﬁca-
tions to alter relative CD4-binding site immunogenicity or
to increase antigenic ﬁdelity to the full length gp120 (Figs.
S3–S5).
Adenovirus-vectored expression of this gp120 outer
domain in A549 mammalian cells showed yields
approaching 50 mg/l after Ni-afﬁnity chromatography and
b12-antibody afﬁnity chromatography from unlabeled,
15N-,
and
15N/
13C-labeled media (Table 1). N terminal analysis
showed the secreted outer domain to start with A-P-R-R-P-
V-V, where the ﬁrst three amino acids were cloning artifacts
and R-P-V-V corresponds toresidues 252–255 of R2 gp120.
SDS–PAGE analysis showed a broad smear of proteins of
varying molecular weights, suggestive of heterogeneous
N-linked glycosylation, and Endo H cleavage, which trun-
cates the high mannose sugars N-linked glycan to the pro-
tein-proximal N-acetyl glucosamine, reduced the smear to a
single tight band (Fig. 2a).
Antigenic analysis with three CD4-binding site reactive
antibodies, b12, b13 and VRC01, showed similar afﬁnities
for glycosylated outer domain expressed in unlabeled,
15N-,
and
15N/
13C-labeled media (TableS4). Although the afﬁnity
to broadly neutralizing antibody b12 was quite tight (*30
nM),theEndoH-deglycosylatedproteindemonstratedfaster
off-rates than observed for the full-length gp120 (Fig. 2b).
For VRC01, the Endo H-deglycosylated protein failed to
bind, perhaps relating to glycan interactions made by
VRC01 or indicating that this outer domain variant did not
perfectly replicate the antigenic behavior of full-length
gp120. Additional modiﬁcations to optimize OD are cur-
rently being assessed; indeed, a driving rationale behind our
NMR analysis of OD is to provide information on structure
and ﬂexibility as a means to facilitate its optimization as an
immunogen to elicit antibodies like VRC01.
HIV-1 gp120 outer domain: isotopic incorporation
The differential glycosylation indicated that mass spec-
trometic characterization of isotope incorporation would
require analysis of tryptic peptides. Analysis of the
sequence for the secreted HIV-1 gp120 outer domain
indicated twelve potential tryptic peptides. Of these, nine
peptides contained the sequence signature for N-linked
glycosylation (N-X-T or N-X-S), one peptide comprised
the C terminal His tag, and the two remaining peptides
had similar masses (842.54 and 835.43 amu). The hep-
tapeptide TIIVQLR at 842.54 amu, was observed in the
mass spectra of outer domain produced in unlabeled
media, but the predicted 835.43 amu fragment was absent.
The percentage incorporation of
15N for the tryptic pep-
tide TIIVQLR in outer domain was estimated to be
85 ± 4% (Kubinyi 1991) (Table 1), and the percent
incorporation in the best-correlated calculated spectrum
was 87% (Fig. 2c).
A similar tryptic digest, MALDI TOF mass spectral
analysis on outer domain expressed in
15N/
13C-labeled
media showed a much more complex m/z distribution
(Fig. 2d). We attribute this to the presence of multiple
species with differential amounts of isotope incorporation
as well as possible overlap from the predicted 835.43 amu
peptide, though we did not observe this peptide in the
15N-
labeled samples. When calculating the percent
13C incor-
poration, we assumed that a similar incorporation of
15N
occurs in the double labeled medium, giving an estimated
13C incorporation of 85 ± 2% with best correlation at 84%
13C incorporation (Table 1 and Fig. 2d).
HIV-1 gp120 outer domain: NMR characterization
One dimensional proton NMR spectra of deglycosylated
HIV-1 gp120 outer domain (Fig. 3a) exhibits a well dis-
persed spectrum with resolved, upﬁeld-shifted methyl
protons as well as a relatively well dispersed amide region,
indicative of a well folded protein. The
1H-
15N HSQC
spectra of the outer domain is of very high quality and
exhibits resolved backbone and side-chain amides;
Table 1 Protein expression levels and isotope enrichment levels of HIV-1 gp120 outer domain using an adenovirus vector-based mammalian
expression system
Unlabeled
15N CGM6000
15N/
13C CGM6000
HIV-1 gp120 outer domain* 34 ± 5 mg/l 45 ± 5 mg/l 44 ± 2 mg/l
15N and
13C isotope incorporation levels
# N/A 85 ± 4% 85 ± 4%, 85 ± 2%
* Yields are based on the total amount of protein obtained after nickel- and antibody-afﬁnity chromatography. Yields are reported as
mean ± SEM
# Percent ranges of isotope incorporation were estimated using the subset of
15N,
13C enrichment levels for which the mass of the highest-
intensity computed peak matched the mass of an observed m/z peak: 852.5 amu for
15N heptapeptide and 884.5 amu for
15N/
13C heptapeptide
(see Table S1, Fig. 2d, and methods)
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123Fig. 2 Characterization of isotopically enriched HIV-1 gp120 Outer
domain expressed using the adenoviral expression system. Production
of isotopically enriched correctly folded post-translationally modiﬁed
proteins is feasible using the adenoviral expression system.
a SDS–PAGE analysis of the HIV-1 gp120 outer domain. Lane UG
glycosylated outer domain demonstrates the micro heterogeneity
observed in the glycans, Lanes U,
15N,
15N
13C deglycosylation of
unlabeled,
15N,
15N/
13C labeled gp120 outer domain with Endogly-
cosidase H resulted in a 28 kDa deglycosylated protein that was used
for biophysical measurements (gel ﬁltration proﬁles are shown in
Fig. S6). Lane M Molecular weight markers. b Surface plasmon
resonance analysis of deglycosylated unlabeled,
15N and
15N/
13C
labeled binding to monoclonal antibodies b12 and b13 demonstrates
that the expressed protein is correctly folded and biologically active.
c Mass spectral analysis of a tryptic peptide fragment TIIVQLR used
to determine % incorporation of
15N. A comparison of experimental
(blue histogram) and computed (maroon histogram) pattern for 87%
incorporation of
15N is shown (left panel). The correlation between
observed experimental pattern and computed patterns are shown for
each percentage incorporation of
15N. d Mass spectral analysis of a
tryptic peptide TIIVQLR to determine % incorporation of
13C. A
comparison of experimental (blue histogram) and computed (maroon
histogram) pattern for 84% incorporation of
13C is shown (left panel).
Although the maximum of the correlation for
13C incorporation is
at 83%, the best ﬁt of the experimental and computational
13C
incorporation was estimated to be 84%, which allows the highest
computational peak to match one of the experimentally-observed
modes (see ‘‘Supplementary methods’’). The correlations between
observed experimental pattern and computed patterns are shown for
each percentage incorporation of
13C with a ﬁxed
15N incorporation
of 84% (right panel)
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123remarkably, we are able to account for 188 of the expected
210 cross peaks in this spectrum (Fig. 3b). Some crowding
is observed in the central region of the HSQC spectrum (dH
7.8–8.2 and dC 118–124 ppm), likely arising from overlap
of backbone amide protons, residual N-acetyl glucosamine
resonances, or the remaining His tag used for puriﬁcation.
The
1H-
13C HSQC (Fig. 3c) exhibits very good chemical
shift dispersion, where numerous Ha and oxymethine
protons can be seen as well as the presence of many upﬁeld
shifted methyl resonances, all of which are indicative of a
structured protein. The excellent signal to noise further
demonstrates the success of the adenoviral expression
method.
A high quality
1H–
1H plane of a
15N edited NOESY-
HSQC spectrum (Fig. 4a) shows the feasibility of obtain-
ing sufﬁcient numbers of NOE assignments for structure
calculations. Finally, the
1H–
13C projection of a 3D HNCO
spectrum (Fig. 4b) demonstrates conclusively that the
adenoviral expression system provides sufﬁcient isotope
enrichment to allow acquisition of triple resonance exper-
iments to obtain full backbone and side chain resonance
assignments. Thus, a good quality H–H plane of a
15N
Fig. 3 Characterization of the HIV-1 gp120 outer domain expressed
and puriﬁed using the adenoviral expression system. One dimensional
proton spectra of deglycosylated unlabeled HIV-1 gp120 outer
domain acquired at 600 MHz equipped with a room temperature
probe at 25C is shown in (a).
1H-
15N and
1H-
13C HSQC acquired at
900 MHz and 25C are shown in (b) and (c), respectively. The outer
domain is an example of a secreted disulﬁde bonded glycoprotein that
is functionally active and the excellent signal to noise demonstrates
the success of the expression method
204 J Biomol NMR (2011) 50:197–207
123edited NOESY-HSQC (Fig. 4a) as well as a
1H–
13C pro-
jection of a 3D HNCO spectrum (Fig. 4b) demonstrates
that the mammalian expression system can provide the
necessary isotopically enriched samples for structural
and dynamic characterization of proteins and protein
complexes.
Discussion
The relative immunogenicity of a particular portion of a
protein is often strongly correlated with its ﬂexibility. For
example, seven ﬂexible loops of the adenovirus hexon with
less than 1% of virion mass accounts for much of adeno-
virus immunogenicity (Huang et al. 2005; Roberts et al.
2006); moreover, the immunogenicity of an epitope placed
into different scaffolds was found to correlate strongly with
the ﬂexibility of the transplanted epitope (Ofek et al. 2010).
Thus the rational design of an HIV-1 envelope immunogen
should take into account its ﬂexibility.
Unfortunately, such information is not so easily attained.
Despite a growing body of biophysical information for
the HIV-1 gp120 glycoprotein—from crystal structures of
gp120 in complex with various ligands (Kwong et al. 1998;
Huang et al. 2005; Zhou et al. 2007, 2010; Chen et al.
2009; Pancera et al. 2010), isothermal titration calorimetry
providing measurements of entropic and enthalpic changes
(Myszka et al. 2000), and hydrogen deuterium exchange
providing a coarse description of conformational stability
(Kong et al. 2010)—an atomic-level description of HIV-1
gp120 ﬂexibility has been missing, and NMR spectroscopy
is one of the only ways to obtain such information.
One barrier to obtaining NMR spectroscopic informa-
tion is the production of isotopically labeled HIV-1 gp120.
HIV-1 gp120 has only been expressed from eukaryotic
cells, and efﬁcient labeling from such cells has in the past
proven problematic. Researchers have used partial or
AATS labeling of proteins from mammalian systems to
obtain structural analysis of a handful of eukaryotic pro-
teins (Takahashi and Shimada 2010), and a number of
research groups have also focused their efforts on devel-
oping cost-effective media suitable for mammalian cell
growth (Skelton et al. 2010). Our goal was to develop an
expression system that produced milligram quantities of
isotopically enriched glycoproteins that would allow solu-
tion structural characterization. Towards this goal we
adapted an adenoviral expression system to obtain post-
translationally modiﬁed
15N and
15N/
13C labeled proteins.
Our approach capitalized on the ability of adenoviruses to
transfect mammalian cells with very high efﬁciency and to
overexpress adenoviral genes to obtain isotopically enri-
ched proteins in milligram quantities. We characterized
the growth of A549 lung carcinoma cells used in the
adenoviral system for protein expression in different
growth media such as DMEM,
15N, and
15N/
13C labeled
CGM6000. A549 cells exhibited similar growth charac-
teristics in labeled CGM6000 media as compared to unla-
beled DMEM (Fig. S1A). NMR analysis of larger proteins
([20–30 kDa) is aided by perdeuteration or random frac-
tional deuteration of carbon-bound hydrogens in a protein,
which can in principle be obtained by growth of mamma-
lian cells in D2O-containing media.
Overall, adenovirus-vector expression in mammalian
cells offers an alternative to manual optimization of media
components, refolding protocols, and/or fermenter growth
that may require additional equipment. The adenoviral
expression system is straightforward to implement and
general in utility. One drawback relative to other eukaryotic
Fig. 4 Heteronuclear NMR
spectroscopy of
15N/
13C HIV-1
gp120 outer domain. A
1H-
1H
plane of a 3D
15N edited
NOESY HSQC acquired on a
*400 lM
15N gp120 outer
domain at 900 MHz is shown in
(a). In b,a
1H-
13C projection of
a 3D HNCO spectrum acquired
on a *400 lM
15N/
13C gp120
outer domain at 900 MHz
further demonstrates that the
adenovirus-vectored
mammalian expression system
can provide the necessary
isotopically enriched samples
for heteronuclear NMR
spectroscopy
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123systems is the time required to obtain recombinant virus
(several weeks), which, nevertheless, is substantially less
than many other steps of the NMR structure-determination
process. At this stage we have only shown incorporation for
15N and
13C, not
2H. However, the ability of adenovirus to
produceGFPin70%D2O(Fig. 1)suggeststhattherequisite
deuteration can be accomplished.
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